EcolabECL
ECL logo
Fair Value
US$317.14
Share price17 Jun
US$274.3113.5% undervalued intrinsic discount
Loading
1Y2.75%
7D-3.19%

Margin Expansion And Digital Solutions Will Drive Outperformance Over The Next Few Years

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
06 Aug 24
Updated
17 Jun 26
Views
528
Not Invested

Last Update 17 Jun 26

Fair value Increased 0.23%

ECL: Pricing Power And AI Data Center Cooling Will Drive Future Upside

Analysts have nudged their fair value estimate for Ecolab slightly higher to about $317 per share, reflecting updated assumptions around modestly stronger revenue growth, a slightly lower discount rate, and continued focus on pricing power and high-tech growth engines highlighted in recent research.

Analyst Commentary

Recent Street research on Ecolab highlights a mix of optimism and caution, with differing views on how much of the company’s pricing power, high-tech exposure, and margin recovery are already reflected in the current valuation.

Bullish Takeaways

  • Bullish analysts see room for Ecolab stock to move higher as pricing actions and energy surcharges are used to offset commodity cost pressures. They view this as supportive for margins and cash flow quality.
  • Several bullish views focus on Ecolab’s high-tech and other growth oriented segments as important volume drivers, underpinning assumptions for stronger long term revenue expansion in their models.
  • UBS highlights the company’s “OneECL” initiatives and a shift toward higher growth industries as reasons to expect structurally better volume trends. This supports its higher price target of US$325.
  • Some bullish analysts point to Ecolab’s “Circle-the-Customer” model, which combines chemistry, equipment, and digital insights, as a way to reinforce pricing power and deepen customer relationships that they see as underappreciated in current valuation multiples.

Bearish Takeaways

  • Bearish analysts question how much upside is left after prior share gains, and several have trimmed price targets. They suggest that execution on pricing, cost recovery, and growth initiatives needs to stay very consistent to justify premium multiples.
  • Some cautious views emphasize that while tools like energy surcharges help manage input costs, they also introduce execution risk if customers push back on pricing. This could affect both volumes and mix.
  • Target cuts from more cautious firms signal concern that expectations for long term sales and earnings growth may already be demanding, especially if high-tech and other growth engines do not deliver as modeled.
  • There is also some skepticism around large transactions such as the US$4.75b CoolIT deal, with questions about valuation and integration. Bears see this as an additional risk factor for Ecolab’s earnings trajectory and return profile.

What’s in the News for Ecolab

  • Wells Fargo raised its Ecolab price target to US$275 with an Equal Weight rating, citing confidence in the energy surcharge program and updated second quarter earnings guidance visibility. (Source: Analysts Raise Ecolab Price Targets Amid Confident Cost Management and Growth Prospects)
  • UBS upgraded Ecolab stock to Buy from Neutral and lifted its price target to US$325, pointing to expectations around pricing recovery, raw material cost management in the second half of 2026, and benefits from OneECL initiatives and consumer market exposure. (Source: Analysts Raise Ecolab Price Targets Amid Confident Cost Management and Growth Prospects)
  • Ecolab announced a US$5b bond issuance intended to help fund the acquisition of CoolIT Systems Inc., which is aimed at reinforcing its position in data center and cooling related solutions. (Source: Analysts Raise Ecolab Price Targets Amid Confident Cost Management and Growth Prospects)
  • The company declared a regular quarterly cash dividend of US$0.73 per share, payable on July 15, 2026, to shareholders of record as of June 16, 2026, marking its 89th year of consecutive dividend payments. (Source: Ecolab Declares $0.73 Quarterly Dividend Amid Strong Q1 Earnings and Positive Analyst Outlook)
  • Ecolab is active in AI enabled water and purification technologies, with recent sector news highlighting acquisitions aimed at strengthening its capabilities in AI driven ion exchange materials as digital water treatment gains more attention. (Source: AI-Driven Ion Exchange Materials Market Attracts $73M in Investment Funding as Water Treatment Digitization Accelerates)

Valuation Changes for Ecolab Stock

  • Fair Value: The fair value estimate has risen slightly from $316.43 to $317.14 per share.
  • Discount Rate: The discount rate assumption has fallen slightly from 7.45% to 7.41%.
  • Revenue Growth: The long term revenue growth assumption has risen slightly from 7.07% to 7.16%.
  • Net Profit Margin: The assumed net profit margin has edged down slightly from 15.49% to 15.45%.
  • Future P/E: The future P/E multiple assumption is essentially unchanged, moving from 34.39x to 34.43x.
8 viewsusers have viewed this narrative update

Key Takeaways

  • Ecolab's One Ecolab initiative focuses on market share gains and value pricing, aiming to improve revenue growth and net margins by delivering exceptional customer value.
  • Strategic pricing adjustments, digital technology investments, and Life Sciences growth position Ecolab for improved operating income margins and long-term earnings potential.
  • Softer demand, international tariffs, and local supplier costs may compress margins, despite strategic investments that could offer long-term growth.

Catalysts

About Ecolab
    Provides water, hygiene, and infection prevention solutions and services in the United States and internationally.
What are the underlying business or industry changes driving this perspective?
  • Ecolab is focusing on expanding its One Ecolab growth initiative, aiming to capitalize on market share gains and increased value pricing. This initiative is expected to drive revenue growth and improve net margins by delivering exceptional value to customers.
  • Investments in digital technologies have led to improved productivity, resulting in a 190-basis-point increase in operating income margin. Continued investment in these technologies is anticipated to enhance earnings and operating margins further.
  • The company has announced a 5% trade surcharge to offset the impact of tariffs, expecting it to bolster organic sales growth and support operating margins by the third quarter. Such strategic pricing adjustments can protect revenue and profitability from global trade fluctuations.
  • Life Sciences is positioned for accelerated long-term growth, with mid-single-digit sales growth and significant share gains in its biopharma business. Investments in innovation and capacity expansion are anticipated to achieve operating income margins close to 30%, positively affecting long-term earnings potential.
  • Ecolab digital experienced a 12% sales growth, primarily driven by subscription revenue, and the company aims to capitalize on this high-margin opportunity by expanding digital offerings. This is expected to significantly impact sales growth and operating income margins as these offerings scale.
Ecolab Earnings and Revenue Growth

Ecolab Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Ecolab's revenue will grow by 7.2% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 12.8% today to 15.5% in 3 years time.
  • Analysts expect earnings to reach $3.1 billion (and earnings per share of $11.17) by about June 2029, up from $2.1 billion today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 34.5x on those 2029 earnings, down from 36.6x today. This future PE is greater than the current PE for the US Chemicals industry at 27.5x.
  • Analysts expect the number of shares outstanding to decline by 0.77% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.41%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Softer demand in heavy industrial markets and expectations of continued softness, particularly as customer production rates in some industries have eased, could impact revenue growth.
  • Rapid changes in international trade policies and global tariffs, particularly the 145% tariff on China, are increasing costs related to raw materials, packaging, and equipment, which could affect net margins.
  • While strategic investments in growth engines like Life Sciences and Pest Intelligence may fuel long-term growth, they could have a near-term impact on operating income margins as these initiatives ramp up.
  • The global onshoring trend has increased local supplier costs due to higher demand, which could compress margins if not offset by cost efficiencies and surcharges.
  • Price surcharges like the newly announced 5% trade surcharge in the U.S. could face resistance from customers, potentially impacting sales volumes and complicating the company's pricing strategy.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $317.14 for Ecolab based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $345.0, and the most bearish reporting a price target of just $270.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $20.2 billion, earnings will come to $3.1 billion, and it would be trading on a PE ratio of 34.5x, assuming you use a discount rate of 7.4%.
  • Given the current share price of $273.87, the analyst price target of $317.14 is 13.6% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Ecolab?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$317.14
vs US$274.3113.5% undervalued intrinsic discount
PastFuture020b2015201820212024202620272029Revenue US$20.2bEarnings US$3.1b
7.2%
Revenue growth
15.5%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Ecolab

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Proven track record average dividend payer.

Market capUS$76.8b
PB7.7x
Estimated Growth6.9%
Dividend Yield1.1%
Full analysis

CEO & management

Christophe Beck
CEO
5.0yrs
CEO Tenure

Provides water, hygiene, and infection prevention solutions and services in the United States and internationally.